8-K: VSee Health Secures $120K Senior Debt, Faces Strict Covenants

VSee Health, Inc. has entered into a Note Purchase Agreement with Ascent Partners Fund LLC, issuing a $133,333.33 Senior Secured Promissory Note for $120,000, due May 2026.

Summary

• VSee Health, Inc. (the "Company") entered into a Note Purchase Agreement with Ascent Partners Fund LLC (the "Investor") on October 9, 2025.
• The Company issued a Senior Secured Promissory Note with a principal amount of $133,333.33 for a purchase price of $120,000, implying an original issue discount of $13,333.33.
• The Note bears interest at 5% per annum and matures on May 8, 2026.
• The Note is secured by the assets of the Company and its subsidiaries (VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc.) through amended Security Agreements and Guaranties, ranking pari passu with existing Dominion Notes.
• The Company is prohibited from entering into variable rate transactions, granting more favorable terms to future debt/security holders without offering them to the Investor, or engaging in certain exchange transactions while the Note is outstanding.
• Mandatory prepayment is required for 100% of net proceeds from any future equity or debt capital raises (Subsequent Offerings) before the Maturity Date.
• An Event of Default triggers an increased interest rate of 24% per annum and immediate acceleration of all outstanding obligations.
• The proceeds from the Note are designated for working capital.

Sentiment

Score: 5

Explanation: The financing provides necessary working capital, which is positive. However, the original issue discount, high default interest rate, and restrictive covenants, particularly the mandatory prepayment from future capital raises, suggest the Company is under some financial pressure and limits its future flexibility. This creates a neutral to slightly cautious sentiment.

Positives

• Secured $120,000 in financing for working capital, which can support ongoing operations.
• The Note is secured by company assets, providing a level of assurance to the lender.

Negatives

• The Note was issued at an original issue discount, meaning the Company received $120,000 but is obligated to repay $133,333.33 in principal.
• A high default interest rate of 24% per annum is imposed upon an Event of Default.
• The Company is subject to restrictive covenants, including prohibitions on certain types of future capital raises (variable-priced equity-linked instruments, exchange transactions) and limitations on incurring additional debt or liens.
• Mandatory prepayment from future capital raises could limit the Company's flexibility in utilizing proceeds from such raises for other strategic purposes.
• A late fee of 10% applies to any obligation not paid when due.

Risks

• Default Risk: Failure to make timely payments, breach of covenants, or other specified events could trigger an Event of Default, leading to immediate acceleration of all obligations and a 24% default interest rate.
• Liquidity Risk: Mandatory prepayment clauses require the Company to use 100% of net proceeds from future capital raises to repay this Note, potentially limiting funds available for other operational or strategic needs.
• Financial Flexibility: Restrictive covenants limit the Company's ability to incur certain types of debt, issue specific equity instruments, or engage in certain transactions, potentially hindering future financing or strategic options.
• Compliance Risk: Failure to comply with SEC reporting requirements (e.g., Rule 144 public information) could result in liquidated damages payments of 2.0% of the principal amount every 30 days.
• Dilution Risk: While not directly convertible, the mandatory prepayment from future equity raises could indirectly impact existing shareholders by diverting capital that might otherwise be used for growth or reducing other liabilities.
• Legal and Regulatory Risk: Non-compliance with Sanctions Laws, AML/CTF Regulations, or other applicable laws could lead to significant penalties and liabilities.

Future Outlook

The proceeds from this financing are designated for working capital, which is expected to support the Company's ongoing operations. No specific forward-looking guidance on financial performance or strategic initiatives was provided beyond this.

Management Comments

• Imoigele Aisiku, Co-Chief Executive Officer of VSee Health, Inc., signed the Note Purchase Agreement and the 8-K filing.
• Milton Chen, Chief Executive Officer of VSee Lab, Inc., signed the Note Purchase Agreement.
• Imoigele Aisiku, Chief Executive Officer of iDoc Virtual Telehealth Solutions, Inc., signed the Note Purchase Agreement.

Industry Context

This filing details a specific debt financing transaction for VSee Health, Inc. and does not provide broader industry context or trends. The terms reflect company-specific financial needs and investor requirements rather than general industry shifts.

Corporate Governance

Legal Proceedings

• To the knowledge of the Company Parties, there is no pending or threatened legal proceeding that would adversely affect the Transaction Documents, involve the SEC or securities regulations, or result in a Material Adverse Effect, except as disclosed in SEC Reports or the Disclosure Certificate.

Related Party Transactions

• The Note Purchase Agreement is with Ascent Partners Fund LLC.
• The Amendment Agreement involves Dominion Capital LLC, which has existing "Dominion Notes" and a "Dominion Equity Line of Credit" with VSee Health, Inc. and its subsidiaries. Ascent Partners Fund LLC is also a holder of some Dominion Notes.
• The new Note ranks pari passu with the Dominion Notes.

Stakeholder Impact

• Shareholders: Potential for future dilution if the Company needs to raise equity to meet mandatory prepayment obligations. Restrictive covenants may limit strategic growth opportunities.
• Creditors (Ascent Partners Fund LLC): Benefits from a secured position, high default interest rate, and protective covenants, including mandatory prepayment from future capital raises.
• Creditors (Dominion Capital LLC): The new note ranks pari passu with existing Dominion Notes, maintaining their relative security position.
• Management: Must ensure strict compliance with numerous covenants and reporting requirements to avoid Events of Default.

Next Steps

• The Company is obligated to make interest payments monthly and repay the principal by May 8, 2026.
• The Company must comply with various covenants, including maintaining public information requirements under Rule 144(c) and restrictions on future financing activities.
• The Company must use the proceeds for working capital as stipulated in the Purchase Agreement.

Key Dates

Recommendation

While securing $120,000 in working capital is a positive for VSee Health, the terms of the Senior Secured Promissory Note, including the original issue discount, high default interest rate, and particularly the restrictive covenants (such as mandatory prepayment from future capital raises and prohibitions on certain equity instruments), suggest the Company is under financial strain and has limited flexibility. For existing equity investors, this debt financing provides short-term liquidity but introduces significant constraints and potential future dilution, leading to a 'hold' recommendation as the long-term implications of these terms need careful monitoring.

Keywords

VSee Health, Senior Secured Promissory Note, Debt Financing, Ascent Partners Fund LLC, SEC 8-K, Corporate Debt, Working Capital, Financial Covenants, Original Issue Discount, Default Interest, Capital Raise, Corporate Governance